Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH

Integrated Cannabis Company, Inc. to Attend the Athens Cannabis Expo 2019


THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) ("Integrated Cannabis"), is excited to announce that X-SPRAYStm successfully exhibited at the 2019 Athens Cannabis Expo in Greece last weekend at the Tae Kwon Do Convention Center in Athens, Greece.

The Expo took place January 11-13 in Athens and attracted industry leaders from across the European Union (EU) and other parts of the globe.  X-SPRAYStm was on display and the company's sales team successfully educated the public on their novel formulations and delivery method.

"The Athens Cannabis Expo was an excellent opportunity for X-SPRAYStm to network with EU cannabis businesses and to expand our European distribution channels," said Mr. John Knapp, CEO of Integrated Cannabis.  He goes on to say, "the European market showed us great promise in 2019 for CBD products. We are positioning ourselves to take full advantage of the changing landscape this year and believe Europe will be a pivotal component for our growth."

X-SPRAYStm connected with dozens of businesses including pharmacies and specialty retailers all of which represented hundreds of retail outlets showing keen interest in carrying our product line.

About Integrated Cannabis Company
Integrated Cannabis Company, Inc. is comprised of dedicated scientists and product engineers who are passionate about health and creating health and lifestyle products utilizing advanced delivery systems and formulations. For more information, please visit the company's website at: www.x-sprays.com.

ON BEHALF OF THE BOARD

"John Knapp"

Chief Executive Officer

For further information, please contact:
Eugene Beukman
Telephone: 604-687-2038
Email: [email protected]

The CSE does not accept responsibility for the adequacy or accuracy of this release. 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.


These press releases may also interest you

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...



News published on and distributed by: